Article
Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity.
Journal of medicinal chemistry - 10 Sept 1998
Venitt S, Crofton-Sleigh C, Agbandje M, Jenkins T C, Neidle S
Abstract excerpt
Fifteen anthracene-9,10-dione ("anthraquinone") derivatives with (omega-aminoalkyl)carboxamido substituents at the 1-, 2-, 1,4-, or 2, 6-ring positions were tested for bacterial mutagenicity in reverse-mutation assays using Salmonella typhimurium frameshift strains TA1538, TA98, and TA97a, in the presence and absence of a metabolic activation system prepared from the livers of rats treated with Aroclor 1254. Six...
Topics
- Animals
- Anthracenes
- Antibiotics, Antineoplastic
- Antineoplastic Agents
- Escherichia coli
- Male
- Mitoxantrone
- Mutagens
- Mutation
- Rats
- Salmonella typhimurium
